Octanate Lv (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a coagulation factor VIII concentrate presented as an intravenous solution for IV use. It replaces deficient factor VIII in patients with hemophilia A, helping to control bleeding episodes. GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octanate Lv is a recombinant factor VIII product that acts within the intrinsic pathway of the coagulation cascade to manage bleeding disorders. - Hemophilia A (severe): Provides factor VIII replacement to prevent and control spontaneous bleeding. - Hemophilia A (moderate): Supports hemostasis during minor surgical procedures and trauma. - Hemophilia A (mild): Used on-demand to treat breakthrough bleeding episodes. - Acquired hemunegative :   -  

Common